Antiperspirant compositions
US-9937113-B2 · Apr 10, 2018 · US
US11090235B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11090235-B2 |
| Application number | US-201313956744-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 1, 2013 |
| Priority date | Aug 2, 2012 |
| Publication date | Aug 17, 2021 |
| Grant date | Aug 17, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Achieving enhanced scent expression in antiperspirant compositions and methods.
Opening claim text (preview).
What is claimed is: 1. A method of enhancing fragrance expression in an antiperspirant composition, comprising the steps of adding the antiperspirant composition components comprising an antiperspirant active, a perfume, non-perfume ingredient, and a non-antiperspirant active ingredient, wherein no more than 17% by weight of the antiperspirant composition, of the non-perfume and non-antiperspirant active ingredients, have a polarity between about 3 MPa 1/2 and 15 MPa 1/2 , into a vessel, heating the vessel, mixing the composition, and then cooling the composition; wherein the antiperspirant composition comprises 11% to 15% of a non-volatile organic fluid; and wherein the antiperspirant composition is anhydrous. 2. The method of claim 1 , wherein the antiperspirant composition comprises less than 4%, by weight of the antiperspirant composition of non-perfume and non-antiperspirant ingredients with a polarity of 15 MPa 1/2 or more. 3. The method of claim 1 , wherein the antiperspirant composition comprises less than 2%, by weight of the antiperspirant composition of non-perfume and non-antiperspirant ingredients with a polarity of 15 MPa 1/2 or more. 4. The method of claim 1 , wherein the antiperspirant composition is substantially free of castor wax. 5. The method of claim 1 , wherein the antiperspirant composition has a hardness of about 600 gram force or more. 6. The method of claim 1 , wherein the antiperspirant composition comprises no more than 15%, by weight of the antiperspirant composition, of non-perfume and non-antiperspirant ingredients with a polarity of between 3.0 MPa 1/2 and 15 MPa 1/2 . 7. The method of claim 1 , wherein the non-perfume and non-antiperspirant ingredients are selected from the group consisting of primary structurant, additional chassis ingredients, other optional ingredients, and combinations thereof. 8. The method of claim 7 , wherein the additional chassis ingredients comprise an additional structurant, a solvent, a non-volatile organic fluid, or combinations thereof. 9. The method of claim 7 , wherein the other optional ingredients comprise a fragrance complexing material, a microcapsule, or a combination thereof. 10. The method of claim 9 , wherein the fragrance complexing material comprises beta cyclodextrin. 11. The method of claim 9 , wherein the microcapsule comprises a polyacrylate microcapsule, a gelatin microcapsule, or a combination thereof.
Related publications grouped by family.
Answers are generated from the same data shown on this page.